Report
ASCO 2022 Pre-conference overview
This pre-conference overview of ASCO 2022 highlights key themes and research areas expected to dominate one of the world’s leading oncology conferences. The event featured more than 5,000 abstracts, 400 exhibitors, over 120 abstract categories, and numerous livestream and plenary sessions, reflecting the scale of innovation across cancer care. Major focus areas included lung cancer, breast cancer, immunotherapy, and acute myeloid leukemia. Emerging themes centered on improving clinical outcomes through targeted therapies, immune checkpoint inhibitors, chimeric antigen receptor (CAR) therapies, stem cell transplantation, endocrine therapy, neoadjuvant treatments, and combination treatment strategies. Researchers also emphasized overall survival, progression-free survival, treatment efficacy
